文献速递冠心病外科

缺血性心肌病患者能否从非体外循环冠脉搭桥获益:KROK登记研究

Do patients with ischaemic cardiomyopathy benefit from off-pump coronary bypass surgery? (From the KROK registry).
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2025-01-01

该研究基于波兰国家心脏手术登记库2012–2022年数据,回顾性比较左室射血分数≤35%的缺血性心肌病患者接受非体外循环与体外循环冠脉搭桥的围术期结局与长期死亡率,经倾向性评分匹配后每组3116例,中位随访4年。非体外循环组30天死亡率更低且围术期并发症更少,但10年随访时体外循环组长期生存略有统计学显著优势。

要点

  • 缺血性心肌病(LVEF≤35%)行单纯冠脉搭桥时,非体外循环可降低30天死亡率(6.4% vs 9.1%,P=0.002)并减少围术期并发症。
  • 长期随访中体外循环组10年生存略有优势(P=0.047),短期获益未转化为长期生存改善。
  • 术式选择应结合患者个体因素与外科团队经验个体化决定。

核心结论

  • 非体外循环冠脉搭桥在缺血性心肌病(LVEF≤35%)患者中提供短期获益,包括降低早期死亡率与减少并发症,但未转化为长期生存改善,体外循环在10年随访显示轻微优势。
  • 术式选择应基于患者特异性因素与外科经验个体化决定。

研究设计与样本

  • 回顾性队列分析,数据来自波兰国家心脏手术操作登记库(KROK registry)。
  • 纳入2012–2022年在波兰接受单纯冠脉搭桥的患者,分为非体外循环组与体外循环组,采用倾向性评分匹配平衡组间差异。
  • 共纳入9920例患者,倾向性评分匹配后每组3116例,中位随访4年。
  • 主要结局为血运重建术后长期全因死亡率。

主要发现

  • 非体外循环组30天死亡率低于体外循环组(6.4% vs 9.1%,P=0.002)。
  • 非体外循环组围术期并发症更少。
  • 10年随访时体外循环组长期生存有轻微但统计学显著的优势(P=0.047)。
  • 中位随访期为4年。

关键数值与推荐

  • 研究人群为左室射血分数≤35%的缺血性心肌病并接受单纯冠脉搭桥者。
  • 倾向性评分匹配后每组3116例,共9920例纳入分析。
  • 30天死亡率:非体外循环组6.4%,体外循环组9.1%,P=0.002。
  • 10年生存比较P=0.047, favoring 体外循环组。

临床怎么用

  • 对LVEF≤35%的缺血性心肌病患者,非体外循环术式可用于降低早期死亡与围术期并发症风险。
  • 不应期望非体外循环带来长期生存获益,长期结局上体外循环可能略有优势。
  • 决策需综合患者个体因素与团队外科经验,而非仅依据术式。

局限性

  • 为回顾性队列研究,尽管采用倾向性评分匹配,仍可能存在未测量混杂。
  • 数据来源于单一国家登记库,外推性需谨慎。
  • 中位随访4年,10年随访数据可能样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to compare perioperative outcomes and long-term mortality between off-pump coronary artery bypass grafting and on-pump coronary artery bypass grafting in patients with ischaemic cardiomyopathy who had a left ventricle ejection fraction of ≤35%. METHODS: A retrospective cohort analysis was conducted using data from the Polish National Registry of Cardiac Surgery Procedures database, encompassing patients who underwent isolated coronary artery bypass grafting in Poland between 2012 and 2022. Patients were divided into two groups: on-pump and off-pump. Propensity score matching was used to balance the groups. The primary outcome was long-term all-cause mortality following surgical revascularization. RESULTS: A total of 9920 patients were included, with 3116 patients in each group after propensity score matching. The median follow-up period was 4 years. The off-pump group was associated with a lower 30-day mortality rate (6.4% vs 9.1%, P = 0.002) and fewer perioperative complications. However, long-term survival analysis revealed a modest but statistically significant advantage for on-pump group at the 10-year follow-up (P = 0.047). CONCLUSIONS: Off-pump provides short-term benefits, including reduced early mortality and fewer complications compared to on-pump technique. However, these advantages do not translate into improved long-term survival, where on-pump demonstrates a slight benefit. The choice between off-pump and on-pump technique should be individualized based on patient-specific factors and surgical expertise.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kosiorowska K, Jasiński M, Przybylski R, et al. Do patients with ischaemic cardiomyopathy benefit from off-pump coronary bypass surgery? (From the KROK registry). Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 39913389. doi:10.1093/icvts/ivaf014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。